Abstract
The independent living donor advocate (ILDA) evaluation must be initiated early in the living donor’s evaluation in order to effectively protect and promote the well-being of the prospective donor. Ongoing assessment and evaluation of the donor candidate’s motivation for donation and their understanding of the inherent medical, psychosocial, and financial risks are essential components. Open-ended questions and a safe environment promote honest disclosure of information from donors. The ILDA must assess for any signs of coercion or undue influence or any type of compensation, tangible or intangible, related to living donation, as these are criteria for exclusion. Identifying areas that require additional education or exploration allows the ILDA to ensure that the prospective donor receives the necessary tools to make an informed decision that is right for the donor.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rudow DL. The living donor advocate: a team approach to educate, evaluate, and manage donors across the continuum. Prog Transplant. 2009;19(1):64–70.
Rudow DL. Role of the independent donor advocacy team in ethical decision making. Prog Transplant. 2005;15(3):298–302.
Bramstedt KA. Living donor transplantation between twins: guidance for donor advocate teams. Clin Transplant. 2007;21:144–7.
Sites AK, Freeman JR, Harper MR, Waters DB, Pruett TL. A multidisciplinary program to educate and advocate for living donors. Prog Transplant. 2008;18(4):284–9.
Dew MA, Jacobs CL, Jowsey SG, Hanto R, Miller C, Delmonico FL. Guidelines for the psychosocial evaluation of living unrelated kidney donors in the United States. Am J Transplant. 2007;7:1047–54.
Bosek MSD, Sargeant IL. Living kidney donor advocacy program: a quality improvement project. JONAS Healthc Law Ethics Regul. 2012 Jan/Mar;14(1):19–26.
Bramstedt KA, Katznelson S. Being Sherlock Holmes: the internet as a tool for assessing live organ donors. Clin Transplant. 2009;23:157–61.
Rodrigue JR, Pavlakis M, Danovitch GM, Johnson SR, Karp SJ, Khwaja K, et al. Evaluating living kidney donors: relationship types, psychosocial criteria, and consent processes at US transplant programs. Am J Transplant. 2007;7:2326–32.
Yang RC, Young A, Nevis IFP, Lee D, Jain AK, Dominic A, et al. Life insurance for living kidney donors: a Canadian undercover investigation. Am J Transplant. 2009;9:1585–90.
Clemens K, Boudville N, Dew MA, Geddes C, Gill JS, Jassal V, et al. The long-term quality of life of living kidney donors: a mulitcenter cohort study. Am J Transplant. 2011;11:463–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Swartz, K. (2014). Components and Timing of the ILDA Evaluation. In: STEEL, J. (eds) Living Donor Advocacy. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9143-9_13
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9143-9_13
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-9142-2
Online ISBN: 978-1-4614-9143-9
eBook Packages: MedicineMedicine (R0)